Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38659855)
Watch
English
The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease.
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
review article
1 reference
stated in
Europe PubMed Central
title
The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
author name string
Williams SF
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
Bitran JD
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
publication date
1 June 1989
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
volume
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
page(s)
319-330
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
cites work
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High–dose melphalan with autologous bone marrow transplant treatment of poor prognosis tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose: a critical factor in cancer chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Twenty years of MOPP therapy for Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous Marrow
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alternating drug combinations in the treatment of advanced Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930559-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(18)30559-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
PubMed publication ID
2663830
1 reference
stated in
Europe PubMed Central
PubMed publication ID
2663830
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663830%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
